Future Prospects of Immunotherapy in Non-Small-Cell Lung Cancer Patients: Is There Hope in Other Immune Checkpoints Targeting Molecules?

Currently, one of the leading treatments for non-small-cell lung cancer is immunotherapy involving immune checkpoint inhibitors. These monoclonal antibodies restore the anti-tumour immune response altered by negative immune checkpoint interactions. The most commonly used immunotherapeutics in monoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Krzyżanowska, Natalia, Wojas-Krawczyk, Kamila, Milanowski, Janusz, Krawczyk, Paweł
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950480/
https://www.ncbi.nlm.nih.gov/pubmed/35328510
http://dx.doi.org/10.3390/ijms23063087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950480/
https://www.ncbi.nlm.nih.gov/pubmed/35328510
http://dx.doi.org/10.3390/ijms23063087

Ejemplares similares